Statin use and risk of diabetes mellitus in postmenopausal women

Clinical Lipidology

Volumn 7, Issue 3, 2012, Pages 267-270

  Katsiki, Niki ^a   Banach, MacIej ^b  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

diabetes mellitus; new onset diabetes mellitus; postmenopausal women; statin

Indexed keywords

ATORVASTATIN; FLUINDOSTATIN; GLUCOSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEVINOLIN; PRAVASTATIN; SIMVASTATIN;

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; ASIAN; BODY MASS; CAUCASIAN; DIABETES MELLITUS; DIETARY INTAKE; DRUG EFFICACY; DRUG USE; EDUCATIONAL STATUS; FAMILY HISTORY; FEMALE; GLUCOSE BLOOD LEVEL; HISPANIC; HORMONAL THERAPY; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; PHYSICAL ACTIVITY; POSTMENOPAUSE; PRIORITY JOURNAL; QUESTIONNAIRE; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; SMOKING;

EID: 84863836796     PISSN: 17460875     EISSN: 17584302     Source Type: Journal    
DOI: 10.2217/clp.12.28     Document Type: Article

References (17)

1. Culver AL, Ockene IS, Balasubramanian R et al. Statin use and risk of diabetes mellitus in postmenopausal women in the Women's Health Initiative. Arch. Intern. Med. 172(2), 144-152 (2012).
2. Sattar N, Preiss D, Murray HM et al. Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials. Lancet 375(9716), 735-742 (2010).
3. Waters DD, Ho JE, DeMicco DA et al. Predictors of new-onset diabetes in patients treated with atorvastatin: results from 3 large randomized clinical trials. J. Am. Coll. Cardiol. 57(14), 1535-1545 (2011).
4. Rajpathak SN, Kumbhani DJ, Crandall J, Barzilai N, Alderman M, Ridker PM. Statin therapy and risk of developing Type 2 diabetes: a meta-analysis. Diabetes Care 32(10), 1924-1929 (2009).
5. Athyros VG, Tziomalos K, Karagiannis A, Mikhailidis DP. Lipid-lowering agents and new onset diabetes mellitus. Expert Opin Pharmacother. 11(12), 1965-1970 (2010).
6. Rubin DB. Estimating causal effects from large data sets using propensity scores. Ann. Intern. Med. 127(8 Pt 2), 757-763 (1997).
7. Athyros VG, Kakafika AI, Tziomalos K, Karagiannis A, Mikhailidis DP. Pleiotropic effects of statins -clinical evidence. Curr. Pharm. Des. 15(5), 479-489 (2009).
8. Kowalski J, Barylski M, Banach M, Grycewicz J, Irzma?ski R, Pawlicki L. Neutrophil superoxide anion generation during atorvastatin and fluvastatin therapy used in coronary heart disease primary prevention. J. Cardiovasc. Pharmacol. 48(4), 143-147 (2006).
9. Preiss D, Sattar N. Statins and the risk of new-onset diabetes: a review of recent evidence. Curr. Opin Lipidol. 22(6), 460-466 (2011).
10. Kostapanos MS, Liamis GL, Milionis HJ, Elisaf MS. Do statins beneficially or adversely affect glucose homeostasis? Curr. Vasc. Pharmacol. 8(5), 612-631 (2010).
11. Freeman DJ, Norrie J, Sattar N et al. Pravastatin and the development of diabetes mellitus: evidence for a protective treatment effect in the West of Scotland Coronary Prevention Study. Circulation 103(3), 357-362 (2001).
12. Mancia G, Bombelli M, Facchetti R et al. Long-term risk of diabetes, hypertension and left ventricular hypertrophy associated with the metabolic syndrome in a general population. J. Hypertens. 26(8), 1602-1611 (2008).
13. Rysz J, B?aszczak R, Banach M et al. Evaluation of selected parameters of the antioxidative system in patients with Type 2 diabetes in different periods of metabolic compensation. Arch. Immunol. Ther. Exp. (Warsz). (5), 335-340 (2007).
14. Karagiannis A, Tziomalos K, Anagnostis P et al. The effect of antihypertensive agents on insulin sensitivity, lipids and haemostasis. Curr. Vasc. Pharmacol. 8(6), 792-803 (2010).
15. Bielecka-Dabrowa A, Aronow WS, Rysz J, Banach M. Current place of beta-blockers in the treatment of hypertension. Curr. Vasc. Pharmacol. 8(6), 733-741 (2010).
16. Katsiki N, Banach M. Statin use and risk of diabetes mellitus in postmenopausal women in the Women's Health Initiative. Arch. Intern. Med. (2012) (In press).
17. Athyros VG, Mikhailidis DP. Pharmacotherapy: statins and new-onset diabetes mellitus-a matter for debate. Nat. Rev. Endocrinol. 8(3), 133-134 (2012).